Single-cell sequencing data from purified CD34+ cells for two patients (MF UPN:950899; PV UPN:374024) demonstrated that mutations detected at the sAML stage were not detected within the JAK2-mutant clones at the MPN stage (Figure 1A). This evidence concerns the gene CD34 and myeloproliferative disorder.